Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Enoxaparin Prophylaxis Using Real-time Anti-Factor Xa Levels in Major Reconstructive Surgery Patients

NCT02687204 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT02687204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02687204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Enoxaparin Prophylaxis Using Real-time Anti-Factor Xa Levels in Major Reconstructive Surgery Patients
Lead sponsor
University of Utah
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2016
Completion date
December 6, 2017
Enrollment
118 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deep venous thrombosis, pulmonary embolus, venous thromboembolism